Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) fell 12.5% during trading on Friday . The stock traded as low as $0.60 and last traded at $0.63. 2,500 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 4,339 shares. The stock had previously closed at $0.72.
ZIVO Bioscience Price Performance
The company has a 50 day moving average of $0.75 and a 200 day moving average of $0.74.
Get ZIVO Bioscience alerts:Institutional Investors Weigh In On ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its holdings in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
ZIVO Bioscience Company Profile
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Featured Stories
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.